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In Brief
N-terminal acetyltransferase (NAT)
proteins mediate N-terminal protein
acetylation, and NatD is among the most
selective NATs, acetylating histones H4
and H2A. Magin et al. report a crystal
structure of NatD bound to an H4/H2A
N-terminal substrate, highlighting the
importance of a Ser-Gly-Arg-Gly
recognition sequence for histone-specific
acetylation.
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N-terminal acetylation is among the most common
protein modifications in eukaryotes and is mediated
by evolutionarily conserved N-terminal acetyltrans-
ferases (NATs). NatD is among the most selective
NATs; its only known substrates are histones
H4 and H2A, containing the N-terminal sequence
SGRGK in humans. Here we characterize the molec-
ular basis for substrate-specific acetylation by NatD
by reporting its crystal structure bound to cognate
substrates and performing related biochemical
studies. A novel N-terminal segment wraps around
the catalytic core domain to make stabilizing interac-
tions, and the a1-a2 and b6-b7 loops adopt novel
conformations to properly orient the histone N
termini in the binding site. Ser1 and Arg3 of the his-
tone make extensive contacts to highly conserved
NatD residues in the substrate binding pocket, and
flanking glycine residues also appear to contribute
to substrate-specific binding by NatD, together
defining a Ser-Gly-Arg-Gly recognition sequence.
These studies have implications for understanding
substrate-specific acetylation by NAT enzymes.
INTRODUCTION
N-terminal acetylation is one of the most widespread protein
modifications in eukaryotes, which occurs in over 60% and
80% of the yeast and human proteomes, respectively (Starheim
et al., 2012). The functional consequence of N-terminal acetyla-
tion is diverse. For example, this modification has been shown
to play a role in the N-end rule for protein degradation through
E3 ligases Ubr1 and Doa10 (Hwang et al., 2010); to be important
for E2-mediated activation of an E3 neddylation enzyme (Scott
et al., 2011); to regulate cell survival pathways through regulation
by Bcl-xL (Yi et al., 2011); to inhibit the targeting of proteins to the
endoplasmic reticulum (Forte et al., 2011); and to facilitate het-332 Structure 23, 332–341, February 3, 2015 ª2015 Elsevier Ltd All rerochromatin formation in yeast (Arnaudo et al., 2013; Yang
et al., 2013). N-terminal acetylation is believed to be an irrevers-
ible process, as no N-terminal deacetylase has been identified
to date (Starheim et al., 2012). Several studies have also con-
nected the aberrant activity of N-terminal acetyltransferases
(NATs) to diseases such as cancer, suggesting that these en-
zymes may be attractive targets for drug development (Kalvik
and Arnesen, 2013).
In eukaryotes, there are five evolutionarily conserved enzymes
responsible for N-terminal acetylation, termed NatA-NatE. NatA-
NatC contain at least two subunits, an auxiliary and catalytic
subunit, whereas NatD and NatE can both be active as mono-
meric enzymes (Starheim et al., 2012). The NATs vary in their
substrate specificity. NatA has the broadest substrate profile
of the NATs and acetylates substrates that have small N-terminal
side chains (Ala, Cys, Gly, Ser, Thr, or Val) (Polevoda and
Sherman, 2003). These N-terminal residues are exposed after
cleavage of the initiator methionine by the action of methionine
aminopeptidases (Huang et al., 1987). The other NATs acetylate
methionine-containing N termini with specificity further dictated
by the identity of at least the second residue. NatB acetylates
proteins that have an N-terminal methionine followed by Asp,
Asn, Glu, or Gln as their second residue (Van Damme et al.,
2012); and NatC and NatE acetylate proteins that have an N-ter-
minal methionine followed by a hydrophobic second residue
(Evjenth et al., 2009; Polevoda and Sherman, 2003). NatF, which
is present only in higher eukaryotes, has a wider variety of sub-
strates and acetylates N-terminal methionines followed by Ala,
Leu, or Lys residues (Van Damme et al., 2011). NATs A, B, C,
and E have been found to associate with the ribosome; it is
believed that N-terminal acetylation is largely a cotranslational
processwherein theNATs acetylate theN terminus as it emerges
from the ribosomal peptide exit channel (Starheim et al., 2012).
NatD (also known as Nat4, Naa40p, or Patt1) activity was first
observed in the yeast Saccharomyces cerevisiae when a NatA
yeast knockout strain was noted to harbor N-terminal acetylated
histones H2A andH4, which contain anN-terminal serine residue
that is typically N-terminally acetylated by NatA (Mullen et al.,
1989). NatD from S. cerevisiae was subsequently cloned (Song
et al., 2003), and the human homolog was later characterized
(Hole et al., 2011). The only NatD substrates known to date areights reserved
Figure 1. Sequence Alignment of NatD Orthologs
The sequence alignment contains the following NatD orthologs: human (Homo sapiens), fission yeast (Schizosaccharomyces pombe), fruit fly (Drosophila
melanogaster), spikemoss (Selaginella moellendorffii), and sea anemone (Nematostella vectensis). The blue boxes represent conserved patches of sequence
alignment. Residues in red are highly conserved, and residues in white with a red background are strictly conserved. Above the sequence alignment are indicated
amino acid numbering forH. sapiens and secondary structure elements. Amino acid residues are indicated that make contacts to the substrate peptide (d), show
mutational sensitivity (+), or are proposed to play catalytic roles (*).histones H2A and H4, making it the most substrate-selective
NAT enzyme so far characterized. Both the human and yeast or-
thologs were found to be associated with ribosomal fractions
from whole cell lysates. Interestingly, the human ortholog local-
ized to the nucleus in addition to the cytoplasm, suggesting
that NatD may act both post- and cotranslationally (Hole et al.,
2011; Polevoda et al., 2009).
The biological role of N-terminal H4 acetylation has only
recently come to light. Schiza et al. demonstrated that the pres-
ence of an N-terminal acetyl group on H4 upregulates rDNA
expression through crosstalk with H4 Arg-3 methylation. The
H4 N-terminal acetyl group inhibits asymmetric dimethylation of
H4 Arg-3 (H4R3me2a) by the Hmt1 arginine methyltransferase
(Schiza et al., 2013).WhenH4R3me2a is found at the rDNA locus,
transcription is repressed. In this way, the presence of an acetyl
group on H4 may act as a sensor for cell growth. NatD has also
been implicated in disease. NatD is downregulated in hepatocel-
lular carcinoma, and overexpression of NatD in the cancerous
cells enhances apoptosis (Liu et al., 2009). NatD liver-specific
knockout male mice have decreased body mass and are pro-
tected from age-associated hepatic steatosis (Liu et al., 2012).
In this study, we set out to understand the molecular basis for
H4- and H2A-specific acetylation by NatD. To do so, we crystal-
lized NatD in binary complex with acetyl coenzyme A (CoA), and
in ternary complex with CoA and an N-terminal histone H4/H2A
substrate peptide, and performed biochemical and enzymatic
characterization of the enzyme.
RESULTS
Overall Structure of NatD
An alignment of NatD sequences from various organisms reveals
a 150-residue region (residues 55–216 in human) of highStructure 23, 33sequence conservation, which we hypothesized mapped to
the acetyltransferase domain (Figure 1). In order to prepare re-
combinant NatD protein variants for biochemical and structural
studies, we bacterially overexpressed several NatD protein
variants derived from Schizosaccharomyces pombe or human.
This led to the identification of S. pombeNatD (SpNatD, residues
13–204) and human NatD (hNatD, residues 17–220) that formed
cocrystals with substrate(s) suitable for X-ray structure determi-
nations. Crystals were prepared of SpNatD and hNatD in the
presence of acetyl-CoA, and of hNatD in the presence of CoA
and an N-terminal histone H4/H2A pentapeptide (SGRGK). Sele-
nomethionine-labeled SpNatD was prepared to determine the
SpNatD/Ac-CoA structure using single-wavelength anomalous
diffraction, and this structure was used to determine the
hNatD/Ac-CoA and hNatD/CoA/peptide structures using molec-
ular replacement. The structures were refined to high quality
and to medium/high resolution (Table 1). The overall SpNatD
and hNatD structures are essentially superimposable, with
a root-mean-square deviation (rmsd) of 1.08 A˚ (Figure 2A). The
remainder of this article describes the human NatD structures,
NatD/Ac-CoA (resolution = 1.78 A˚, Rfree/Rwork=20.6%/16.9%)
and NatD/CoA/peptide (resolution = 2.5 A˚ (Rfree/Rwork=22.3%/
17.5%).
The overall NatD structure has a mixed a/b GCN5-like fold
(Figure 2B) similar to the other reported NAT structures (Liszczak
et al., 2011; Liszczak et al., 2013; Liszczak and Marmorstein,
2013). However, there are notable differences between NatD
and the other NAT structures, NatA and NatE (Figure 3A). In
particular, differences are noted in the loops forming the peptide
binding site, and NatD contains a unique N-terminal segment.
A striking divergent feature of NatD is its loops flanking the
substrate binding site, b6-b7 and a1-a2. A characteristic feature
of the peptide binding site of the NAT proteins is that these loops2–341, February 3, 2015 ª2015 Elsevier Ltd All rights reserved 333
Table 1. Data Statistics for NatD Crystal Structures
Selenomethionine
SpNatD
hNatD/
acetyl-
CoA
hNatD/CoA/
H4-H2A
Peptide
PDB ID 4AU3 4U9V 4U9W
Crystal Parameters
Space group C2 C2 P21
Cell dimensions
a, b, c, (A˚) 114.701, 42.629,
85.417
88.256,
44.064,
50.356
52.901,
93.288,
100.329
a, b, g () 90.00, 98.68,
90.00
90.00,
95.44,
90.00
90.00,
96.69, 90.00
Data Collectiona
Resolution (A˚) 50–1.85
(1.92–1.85)
50–1.78
(1.84–1.78)
50–2.50
(2.59–2.50)
Unique
reflections
34807 18519 33496
Rmerge 0.067 (0.595) 0.074
(0.471)
0.102 (0.552)
I/sI 32.6 (6.1) 22.6 (1.7) 12.3 (2.3)
Completeness
(%)
99.4 (98.7) 98.5 (87.5) 98.8 (97.6)
Redundancy 17.4 (16.7) 8.1 (4.2) 3.8 (3.7)
Refinement
Rwork/Rfree (%) 17.9/23.8 16.9/20.6 17.5/22.3
No. of atoms
Protein 3132 1582 6348
Acetyl-CoA/
CoA
96 51 192
Peptide N/A N/A 125
Solvent 234 166 457
B factors (A˚2)
Protein 64.63 23.99 26.61
Acetyl-CoA/
CoA
62.97 21.59 24.92
Peptide N/A N/A 25.85
Solvent 77.18 32.57 27.23
Root-mean-
square
deviation
Bond
lengths (A˚)
0.007 0.009 0.010
Bond
angles ()
1.078 1.126 1.206
Ramachandran
statistics (%)
Favored 100 97.44 98.72
Allowed 0 2.56 1.15
Outlier 0 0 0.13
aValues in parentheses are for the highest resolution shell.
Figure 2. Overall Structure of NatD Complexes
(A) Superposition of the SpNatD/acetyl-CoA (violet), hNatD/acetyl-CoA
(brown), and hNatD/CoA/H4-H2A peptide (cyan) complexes. CoA is shown as
sticks, and the H4-H2A peptide is omitted for clarity.
(B) Overall structure of hNatD/CoA/H4-H2A peptide with structurally unique
elements of NatD relative to other NATs highlighted in yellow. CoA is shown in
orange and H4 is shown in magenta.
334 Structure 23, 332–341, February 3, 2015 ª2015 Elsevier Ltd All rappear to be used to prevent internal lysines from inserting into
the active site. This is in contrast to the more open loop config-
uration of lysine acetyltransferases such as Gcn5 (Rojas et al.,
1999) and Hat1 (Li et al., 2014). In the case of NatA and NatE,
a b6-b7 hairpin loop serves this function. In NatD, the corre-
sponding b6-b7 hairpin loop is flipped away from the substrate
binding site, and instead, the binding pocket is blocked by an
extended a1-a2 loop on the opposite side (Figure 3B). As dis-
cussed below, this difference appears to be critically important
for substrate-specific binding by NatD.
The novel NatD N-terminal segment (residues 24–51) adopts a
helix-loop-strand topology that wraps around the catalytic core
domain, making complementary interactions with a hydrophobic
patch, which appears to be important for stability of the protein
(Figure 3C). The interface between the N-terminal segment and
a cleft on a surface of the catalytic core domain is largely hydro-
phobic. Specifically, residues Pro-38, Leu-39, Phe-42, Phe-45,
and Tyr-48 of the N-terminal segment make van der Waalsights reserved
Figure 3. Unique Structural Features of NatD
(A) Superposition of hNatD (cyan), SpNatA (orange), and hNatE (green) complexes. The H4-H2A peptide is shown inmagenta. Only the CoA from the hNatD/CoA/
H4-H2A peptide structure is shown for clarity.
(B) Close-up view of the substrate binding groove of NatD in comparison with NatA and NatE. The color coding is as in Figure 3A. NatA substrate (SASE) and NatE
substrate (MLGP) are shown as orange and green sticks, respectively.
(C) View of the interaction of the NatD N-terminal segment (yellow cartoon representation) with the catalytic core domain (cyan surface representation).
(D) Detailed interactions between the N-terminal segment and catalytic core domain of NatD. Residues from the N terminus that mediate interactions are labeled
in black, and residues from the core domain are colored in dark blue and labeled in white. Met-162 is omitted for clarity.contacts to residues Leu-53, Ile-57, Cys-59, Trp-107, Leu-109,
Phe-124, Phe-126, Leu-151, Phe-154, Ile-158, Leu-161, and
Met-162 of the core domain (Figure 3D). Consistent with the
importance of these contacts for stability of the catalytic core
domain, N-terminally truncated proteins beginning at residue
47 were not stable through purification, yet constructs beginning
at residue 37 were (data not shown). The region from residues
37–48 contains the key hydrophobic residues that interact with
the hydrophobic surface cleft of the core domain. Notably, the
residues that line this hydrophobic cleft are replaced with more
hydrophilic residues in the other NAT proteins, which explains
why they lack the extended N terminus. We have designated
the a helix and b strand in this novel N-terminal region a0 and
b0, respectively, in order to keep secondary structure nomencla-
ture consistent with the other NAT proteins (Liszczak et al., 2011;
Liszczak et al., 2013; Liszczak and Marmorstein, 2013).
Substrate Recognition by NatD
The structure of NatD in complex with CoA and the N terminus of
histones H4/H2A provides important insights into substrateStructure 23, 33binding. The overall structure of the protein from the ternary
complex is similar to the binary complex, with an rmsd of
0.313 A˚. The density for the peptide is well defined, and we
were able to unambiguously place all atoms expect for the
Lys5p side chain. The binding pocket for the peptide is highly
acidic, which is in line with the basicity of the histone tails (Fig-
ure 4A). The ternary complex reveals extensive interactions
with the substrate peptide and NatD (Figure 4B). Notably, con-
tacts occur along the entire length of the peptide; each amide ni-
trogen and oxygen is hydrogen bonded, except for the Arg3p
amide oxygen. There are direct hydrogen bonds to the backbone
amide groups on the peptide from residues Tyr-138, Thr-174,
Ser-197, and Tyr-211 of NatD. In addition, there are water-medi-
ated contacts between residues Glu-100, Tyr-136, and Thr-174
to the backbone amides of the peptide. The aliphatic region of
Trp-90 interacts with Gly2p and Gly4p of the peptide via van
der Waals contacts. Ile-213 makes van der Waals contacts
with the backbone of Lys5p.
The residues along the peptide path are poised to confer spec-
ificity for recognition by the enzyme. Ser1p sits in a pocket, which2–341, February 3, 2015 ª2015 Elsevier Ltd All rights reserved 335
Figure 4. Peptide Binding Site of NatD
(A) Electrostatic surface of the NatD peptide binding site with the peptide
shown in magenta stick figure. Residues from NatD are labeled in black and
residues from the peptide are labeled in yellow with their corresponding one-
letter codes and numerical positions in the peptide. The side chain of Lys5p
was disordered and not modeled into the crystal structure.
(B) Detailed interactions between NatD and the H4-H2A peptide. NatD is
shown as a transparent cyan surface, and residues that interact with the
peptide are yellow. Hydrogen bonds are shown as dashed lines and waters are
shown as red spheres.
(C) Close-up view of the NatD active site highlighting interactions made by
Ser1p. Acetyl-CoA was modeled into the figure by aligning the binary and
ternary NatD structures.would not accommodate residues with larger side chains, as
they would be occluded by Met-81, Tyr-85, and Glu-139. There
are two water molecules in an extended network of hydrogen336 Structure 23, 332–341, February 3, 2015 ª2015 Elsevier Ltd All rbonds that fill the other side of the pocket (Figure 4C). In addition
to the size restrictive pocket, the side chain of Ser1p makes
hydrogen bonds to Tyr-85 and Glu-139. Arg3p makes numerous
contacts with NatD as well (Figure 4B). The aliphatic region of the
Arg3p side chain sits on top of Tyr-136 in an extensive van der
Waals interaction. The two terminal nitrogens in the guanidino
group of the side chain make hydrogen bonds with the NatD
side chains Asp-127, Glu-129, and Tyr-138. The glycines at po-
sitions 2 and 4 also appear to be playing important roles in pep-
tide substrate recognition by NatD. It is notable that Gly2p is in a
conformation with torsion angles that are unfavorable for any
residues other than glycine in the Ramachandran plot (Phi:
69.59, Psi: 171.02). In addition, both Gly2p and Gly4p are in
grooves that are sterically tailored for glycines. Gly2p lies in a nar-
row tunnel, which connects Ser1pwith the rest of the peptide and
is in close contact with Lys-97 and Glu-100. Gly4p makes inti-
mate contacts with Trp-90, Thr-174, and Tyr-211. It appears
that residues with side chains in position 2 or 4 would thus
lead to unfavorable clashes (Figure 4B). The majority of the res-
idues making contacts with the peptide are highly conserved
among NatD homologs (Figure 1).
To address the contribution of specific residues in substrate
recognition, we prepared point mutants to alanine for residues
of interest and assayed them for acetyltransferase activity
against a 19-residue peptide of the H4 N terminus (Figure 5A).
All of the mutants assayed were purified to homogeneity in the
same manner as the wild-type enzyme and displayed the same
gel filtration elution profile, suggesting that the mutants did not
perturb overall protein folding. Individual mutations of residues
that contribute to the intimate Gly4p interaction (T174A and
Y211A) show wild-type catalytic efficiency (Figures 5A and 5B).
In contrast, mutations of residues that contact Arg3p (Y136A,
Y138A, and D127A/E129A) show significantly decreased cata-
lytic efficiency (1.6- to 18-fold) (Figures 5A and 5B), highlighting
the particular importance of this residue for substrate-specific
binding. The W90A and Y85A mutants also exhibited markedly
decreased catalytic efficiency (2.8- and 5.8-fold, respectively).
The W90A mutant lacks the stabilizing van der Waals contacts
with the peptide. The decrease in activity in the Y85A mutant is
likely due to the absence of hydrophobic stabilization provided
by Tyr-85 in the a1-a2 loop that forms a part of the cavity for his-
tone recognition, in addition to its hydrogen bond to Ser1p (Fig-
ures 5A and 5B). Glu-100 is a highly conserved residue that may
act to position a1 and a2 through an interaction with Lys-97,
another conserved residue. This is supported by the observation
that an E100A mutation exhibits a 5-fold reduction in catalytic
efficiency. Notably, Lys-97 mutants were not stable through
purification (data not shown).
NatD Catalysis
The structure of NatD suggests several potential catalytic resi-
dues. Classically, acetyltransferases in the GNAT family use a
general base residue to deprotonate the lysine side chain or N
terminus, which carries out a nucleophilic attack on the acetyl
group of acetyl-CoA (Yuan and Marmorstein, 2013). Interest-
ingly, the type and relative location of residue that is used to carry
out this function can differ between acetyltransferase enzymes
(Liszczak et al., 2011; Liszczak and Marmorstein, 2013; Vetting
et al., 2005). In the NatD structure, both Tyr-136 and Glu-139ights reserved
Figure 5. Mutational Analysis of NatD
(A) Catalytic efficiency of selected NatD mutants.
Mutations that have negligible effect are in blue,
while those that decrease the catalytic efficiency of
the enzyme are in pink.
(B) Residues targeted for mutagenesis are mapped
onto the NatD structure. The color scheme is the
same as Figure 5A.
(C) The catalytic efficiency of wild-type NatD to-
ward N-terminal histone H4 peptides of varying
length. Data are represented as mean ± SEM. Each
mutant and peptide of varying length was assayed
in triplicate.are positioned to potentially play a role as important catalytic
residues (Figures 4B and 4C). Although Tyr-136 is not close
enough to deprotonate the N terminus directly, there is an or-
deredwatermolecule bridging its phenol oxygen and the peptide
N terminus. This water molecule is positioned similarly to one
that appears to be involved in catalysis in NatE, which uses a
tyrosine as one of its general bases (Liszczak et al., 2011). In or-
der to distinguish between the two residues, wemutated Tyr-136
to phenylalanine andGlu-139 to glutamine and tested the activity
of these mutants. While the catalytic efficiency of the enzyme is
modestly affected by the Y136F mutation, it is effectively abol-
ished in the E139Q mutant, demonstrating that the catalytic res-
idue of NatD is likely Glu-139 (Figure 5A). This is in agreement
with a previous study (Liu et al., 2009) and consistent with the
functional importance of Glu-139, as it is strictly conserved
among NatD proteins (Figure 1). As Glu-139 is not positioned
to directly deprotonate the N terminus, it may not act as a general
base but instead increase the nucleophilicity of the N terminus
through an induced dipole effect from the carboxylic acid side.
Glu-139 may also be important for orienting the amino group
properly across from the acetyl-CoA. This is similar to Glu-24
in NatA, which is not directly positioned to deprotonate the
N terminus but is essential for catalysis (Liszczak et al., 2013).
Our results are in contrast to previous reports on the catalytic
requirements of NatD. A previous modeling study predicted that
Cys-137 could also act as an important residue in the catalytic
mechanism of NatD (Jedrzejewski and Kazmierkiewicz, 2013),Structure 23, 332–341, February 3, 2015in a mechanism similar to MYST family
acetyltransferases (Yan et al., 2002). How-
ever, the cysteine is not in a suitable posi-
tion in the structure to act as an acetyl
group acceptor, and while the C137A
mutant does show a decrease in activity,
it still retains much of its catalytic power
(Figure 5A). Previous studies also sug-
gested that NatD requires a longer N-ter-
minal tail than other NATs in order to
recognize its histone H4 and H2A sub-
strates. In particular, in an in vivo assay
in S. cerevisiae, it was found that chimeric
cytochrome c with H4 N termini showed
complete acetylation with chimeric pro-
teins containing 50 N-terminal H4 resi-
dues, and only incomplete acetylationwith chimeric proteins containing 30 N-terminal H4 residues
(Polevoda et al., 2009). However, when we tested synthetic H4
peptides of varying length (5, 8, and 19 residues) we did not
see a significant difference in catalytic efficiency (Figure 5C).
This result is in agreement with the crystal structure, suggesting
that the determinants for NatD-specific binding and acetylation
are contained within the first four N-terminal residues. It is also
consistent with a previous study, which showed that NatD
substrate specificity is not affected by residues past the fifth
position in a peptide when the enzyme was tested against a
library of oligopeptides (Hole et al., 2011).
DISCUSSION
The structures and biochemical activities of two of the six NAT
proteins have recently been characterized, NatE (Liszczak
et al., 2011) and NatA (Liszczak et al., 2013). Here, we report
the molecular characterization of one of the most substrate-se-
lective NAT enzymes, NatD, which has been reported to acety-
late the N terminus of only two substrates (histones H4 and
H2A) that harbor the identical sequence of SGRGK in humans.
We find that the overall fold of NatD is similar to other NATs; how-
ever, there are structural differences that appear to be critical for
maintaining protein integrity and cognate substrate binding. A
novel N-terminal segment wraps around the catalytic core
domain to make numerous stabilizing interactions, and deletion
analysis suggests that this N-terminal segment is required forª2015 Elsevier Ltd All rights reserved 337
Figure 6. Comparison between Substrate
Recognition of NatD and NatA
(A) Overlay of the peptide binding site of NatA
(orange) and NatD (cyan with magenta histone
substrate).
(B) Electrostatic potential surface of the NatA
active site with a bound covalently linked bisub-
strate inhibitor. The N-terminal serine of the
substrate peptide is shown in orange, and the
acetyl-CoA moiety of the bisubstrate inhibitor is
in white.
(C) Electrostatic potential surface of the NatD
active site. The N-terminal serine of the substrate
peptide is shown in magenta, and acetyl-CoA is in
orange. Waters are shown as red spheres. Acetyl-
CoA was modeled into the figure by aligning the
binary and ternary NatD structures.maintaining the stability of the catalytic core domain. We note
that several NAT proteins (NatA, NatB, and NatC) require auxil-
iary subunits for activity; the NatA structure reveals that the
Naa15p auxiliary subunit wraps around the Naa10p catalytic
subunit to increase stability of the catalytic subunit to induce a
conformation of Naa10p that is compatible for catalysis (Liszc-
zak et al., 2013). In this regard, the N-terminal segment of
NatD may play an analogous role as the NatA auxiliary subunit.
The N-terminal sequence requirements of NatD are different
from other NATs. In particular, most other NATs show the great-
est specificity for residue 1, with reduced preference for residue
2 and significantly reduced preference for residues 3 on (Star-
heim et al., 2012). This is borne out by the crystal structures of
NatA and NatE bound to cognate peptides, showing the most
extensive side chain interactions with residue 1 followed by res-
idue 2 of the cognate substrate (Liszczak et al., 2011; Liszczak
et al., 2013). NatD, in contrast, has sequence requirements for
the first 4 residues of its substrate peptide (Hole et al., 2011).
Unique structural features of NatD appear to play direct roles
in substrate-specific binding by NatD. In particular, the b6-b7
loop of NatD is oriented away from the peptide substrate binding
site relative to the corresponding loops in the other NATs.
Instead, the extended a1-a2 loop of NatD flips toward the pep-
tide binding site and in so doing tilts the path of the NatD peptide
by about 75 relative to the paths of the NatA and NatE sub-
strates (Figure 3B). An important consequence of this is that
Arg3p is forced into a unique and complementary pocket of
NatD that is not present in the other NATs and particularly not
in NatA, which also acetylates N termini that contain a serine in
position 1 (Figure 6A). Indeed, both NatA and NatE contain a
conserved tyrosine (Tyr-138 in both proteins) that would steri-
cally block peptides from being oriented toward the b6-b7 loop
as in NatD. This may be a mechanism by which NatA and NatE
ensure a broader substrate profile, as orienting the peptide
away from the enzyme surface prevents significant interaction
beyond the first two residues of the N terminus.
The Arg3p pocket also raises the intriguing question of whether
Arg3 methylation may inhibit H4 acetylation. H4 N-terminal acet-
ylation inhibits Arg3 asymmetric dimethylation in yeast (Schiza
et al., 2013), and based on our structural data, it may be the
case that Arg3p methylation also inhibits N-terminal acetylation.338 Structure 23, 332–341, February 3, 2015 ª2015 Elsevier Ltd All rIf Arg3p were methylated, and particularly asymmetrically dime-
thylated, we predict that it would disrupt the hydrogen bond
network in its binding pocket (Figure 4B) and therefore occlude
substrate binding and acetylation.
Similarly to NatA, the peptide binding pocket of NatD can only
accommodate residues with small side chains as position 1 in
the peptide. However, unlike NatA, the pocket is more tailored
to accommodate a serine. Tyr-85 and Glu-139 are oriented to
have their side chains precisely where the side chain of theN-ter-
minal residuewill lie in the pocket (Figure 4C).Whereas the active
site of NatA lacks significant electrostatic potential (Figure 6B),
the presence of these polar and charged residues in the active
site likely makes it unfavorable for residues with small aliphatic
side chains to be the N-terminal residue in the peptide (Fig-
ure 6C). In addition, the active site pocket of NatD is even
more constricted than NatA, particularly due to the placement
of Glu-139. This helps explain the preference for serine over thre-
onine, a residue that NatA can acetylate. Gly2p and Gly4p of the
H4/H2A peptide also appear to contribute to substrate-specific
binding by NatD. Gly2p contains unusual Phi/Psi angles, which
are only favorably accommodated by a glycine residue, and it
does not appear that a residue with a side chain would be steri-
cally accommodated in positions 2 or 4 of a substrate. hNatD
therefore appears to be specific for a Ser-Gly-Arg-Gly sequence
in its cognate substrate. Notably, S. cerevisiae H2A has a
divergent sequence of SGGKG. It was shown that heterologous
expression of human NatD in an S. cerevisiae NatD knockout
strain restored N-terminal acetylation of yeast H4 but not yeast
H2A in vivo (Hole et al., 2011). Therefore, the substrate specific-
ities of NatD correspond to the sequences of H2A and H4 in the
organism, and yeast NatD has likely evolved to accommodate
both N termini.
Given the fairly short consensus sequence of NatD, we
wondered why NatD is specific for histones H4 and H2A. We first
performed a Uniprot search to query what other proteins share
an N-terminal SGRGK sequence. To our surprise, the only pro-
teins containing this N-terminal sequence in the human prote-
ome are H2A, H4, and H2A.X. If we decrease our specificity by
removing Lys-5 (which does not appear to make sequence-spe-
cific interactions in the structure), there is only one other protein
with an N terminus of SGRG, an SWI/SNF- related chromatinights reserved
regulator called SMARCD2 (Ring et al., 1998). There is no
evidence that SMARCD2 is acetylated by NatD, but our studies
predict that this would be the case. There are an additional 17
proteins in the human proteome with an N terminus of SGR
that may also be substrates for NatD. Importantly, this method
does not account for N termini generated through proteolytic
cleavage, nor for any hitherto undiscovered N termini that
diverge from the sequence of SGRG but may still act as sub-
strates for NatD. However, it still appears that theN-terminal pro-
teome of potential NatD substrates is limited relative to other
NAT proteins. Further studies will have to be carried out to estab-
lish if the pool of NatD client proteins is indeed broader than pre-
viously appreciated.
EXPERIMENTAL PROCEDURES
Homo sapiens NatD (hNatD) Expression and Purification
The full-length hNatD gene (encoding residues 1–237) was a gift from Dr
Thomas Arnesen from the University of Bergen. Several N-terminal and C-ter-
minal truncation constructs were engineered into amodified PCDF vector con-
taining an N-terminal tobacco etch virus (TEV) protease-cleavable His tag. All
constructs were transformed into Rosetta (DE3)pLysS competent Escherichia
coli cells, which were grown to an OD600 of 0.7–0.9 and induced with 0.5 mM
isopropyl b-d-1-thiogalactopyranoside (IPTG) at 16C for 16 hr. All subse-
quent purification steps were carried out at 4C. Cells were isolated by centri-
fugation and lysed by sonication in lysis buffer containing 25 mM Tris, pH 8.0,
1 M NaCl, 10 mM b-mercaptoethanol (bME) and 10 mg/ml phenylmethanesul-
fonylfluoride. The lysate was clarified by centrifugation and passed over nickel
resin (Thermo Scientific), which was subsequently washed with >20 column
volumes of lysis buffer supplemented with 25 mM imidazole. The protein
was eluted in lysis buffer supplemented with 300 mM imidazole. His tagged
TEV protease was added to the eluent containing the target protein for the
duration of a 14 hr dialysis into dialysis buffer containing 25 mM Tris, pH 8.5,
200 mM NaCl, 10 mM bME. This solution was passed through an additional
nickel column to remove TEV protease as well as any uncut NatD. The resin
was then washed with approximately seven column volumes of dialysis buffer
supplemented with 25 mM imidazole, which was pooled with the initial flow-
through. This solution was dialyzed into ion exchange buffer containing
25 mM Tris, pH 8.5, 50 mM NaCl and 1 mM dithiothreitol (DTT) and loaded
onto a 5 ml HiTrap Q ion exchange column (GE Healthcare). The protein was
eluted in the same buffer with a salt gradient (50–750mMNaCl) over the course
of 20 column volumes. Peak fractions were pooled and dialyzed into sizing
buffer containing 25 mM HEPES, pH 7.0, 200 mM NaCl, and 1 mM DTT for
16 hours. This was concentrated to a volume of 500 ml (10 kDa concentrator;
Amicon Ultra, Millipore), and loaded onto and run on an s75prep gel filtration
column (GE Healthcare) in sizing buffer. Peak fractions were concentrated to
10 mg/ml as measured by UV280 for crystallization trials.
S. pombe NatD (SpNatD) Expression and Purification
The full-length SpNatD gene (encoding residues 1–204) was cloned from the
S. pombe genome (ATCC), and several N-terminal truncation constructs
were engineered into a modified pETDUET vector containing a TEV prote-
ase-cleavable His tag. All constructs were transformed into Rosetta (DE3)
pLysS competent E. coli cells, which were grown to an OD600 of 0.7–0.9 and
induced with 0.5 mM IPTG at 16C for 16 hr. These constructs all expressed
as insoluble inclusion bodies in Rosetta (DE3)pLysS E. coli cells. To improve
solubility, a number of constructs of the SpNatD gene were subcloned into a
modified pETDUET vector containing an N-terminal SUMO tag. These con-
structs were transformed and induced with IPTG in the same way and were
soluble in E. coli cells. All subsequent studies were carried out at 4C and
are identical to the purification protocol used for purifying the human protein,
with the following changes. After the nickel column, His tagged Ulp1 protease
was used in place of TEV protease to cleave the SUMO tag. The ion exchange
buffer contained 25 mM HEPES, pH 7.0, 50 mM NaCl, and 1 mM DTT, and a
5 ml HiTrap SP ion-exchange column (GE Healthcare) was used. The seleno-
methionine derivative was produced by expressing the SUMO tagged SpNatDStructure 23, 33(residues 13–204) in minimal media (Molecular Dimensions) with 50 mg/l sele-
nomethionine (Sigma) purified in the same manner as above.
NatD Crystallization and Data Collection
hNatD (8 mg/ml) was incubated with acetyl-CoA (Sigma-Aldrich) at a 1:3 molar
ratio. Crystals were obtained with hanging-drop vapor diffusion in a drop con-
taining a 1:1 mixture of protein to a well solution containing 20% PEG 3350,
200 mM sodium citrate tribasic dihydrate, 100 mM citric acid, pH 4.0. Diffrac-
tion-quality crystals grew in 2–3 days. The ternary complex was crystallized
using an hNatD construct containing residues 17–220 at 10mg/ml. The protein
was incubated with CoA, and the C-terminally amidated substrate peptide
(SGRGK, GenScript) at a 1:3:5 molar ratio of protein:CoA:peptide. Crystals
were obtained through hanging-drop vapor diffusion at 20C at a 1:1 ratio of
protein to a well solution containing 20% PEG 3350 and 200 mM sodium
malonate, pH 6.0. Crystals grew after 1 day. SpNatD was crystallized at a con-
centration of 10 mg/ml using a construct that contained residues 13-204. The
protein wasmixedwith acetyl-CoA at amolar ratio of 1:3 protein to acetyl-CoA.
Crystals were obtained with hanging-drop vapor diffusion at 20C at a 1:1 ratio
of protein to well solution containing 20% PEG 3350 and 200 mM potassium
formate. Crystals grew after 1 day. Selenomethionine crystals of SpNatD
were generated in the same manner. All crystals were cryoprotected by trans-
ferring them to their respective well solutions supplemented with 20% glycerol
before being flash frozen in liquid nitrogen. Data for the hNatD ternary complex
were collected at a home source using a MicroMax-007 HF rotating anode
(Rigaku). Data for all other crystals were collected at beamline X29A at the
National Synchrotron Light Source (Brookhaven National Laboratory). All
data sets were processed using HKL2000 (Otwinowski and Minor, 1997).
Structure Determination and Refinement
Initially, a number of full-length and truncated search models based on known
structures of NATs (Liszczak et al., 2011; Liszczak et al., 2013; Liszczak and
Marmorstein, 2013) were used in an attempt to solve either hNatD or SpNatD
structure throughmolecular replacement (McCoy et al., 2007). However, these
attempts were unsuccessful in generating a suitable starting model for either
hNatD or SpNatD. A data set was collected on the selenomethionine-labeled
SpNatD crystals at the selenium peak wavelength (0.9788 A˚), heavy atoms
were placed in the asymmetric unit, and initial phases were generated using
single-wavelength anomalous diffraction phasing using SOLVE in the Phenix
suite (Adams et al., 2011). The SpNatD structure was initially built into the re-
sulting density by AutoBuild in the Phenix suite. The rest of the structures
described were determined using molecular replacement. The selenomethio-
nine-labeled SpNatD structure was used as a search model for the wild-type
SpNatD crystals. However, these crystals did not yield a model of sufficient
quality, so only the selenomethionine data set was refined fully. The program
CHAINSAW (Stein, 2008) was used to generate a search model from the
SpNatD structure for the binary hNatD structure, and the final refined hNatD
structure was used as a search model for the ternary hNatD crystals. For all
of the structures, the ligands acetyl-CoA/CoA and the substrate peptide for
the ternary complex were built into the Fo  Fc electron density map. All of
the structures were refined iteratively by using Phenix.Refine and manual
model building in the molecular graphics program Coot (Emsley et al., 2010).
The SpNatD/acetyl-CoA complex crystallized as a dimer with the N terminus
of one monomer in the active site of another. The N-terminal serine of the
enzyme is acetylated, and CoA is bound to the enzyme. This is likely an artifact
of crystallization, wherein the subunit packing positions the N terminus of
SpNatD (SRRMK), which superficially resembles the natural substrate, in the
active site. The final model and structure factors for all of the structures
were submitted to the Protein Data Bank (PDB). Refinement statistics and
PDB IDs can be found in Table 1.
Acetyltransferase Assays
Acetyltransferase assays were carried out in 25 mM HEPES pH 7.0, 100 mM
NaCl, and 1 mM DTT. The substrate peptide used in the assay for the
mutant enzymes corresponds to the first 19 residues of human H4 (NH2-
SGRGKGGKGLGKGGAKRHR-COOH; GenScript). In the assay, a saturating
amount (400 mM) of radiolabeled [14C]acetyl-CoA (4 mCi/mmol; PerkinElmer
Life Sciences) and varying concentrations of the substrate peptide (6.25–
200 mM) were incubated with 75 nM hNatD (500 nM for E139A and E139Q2–341, February 3, 2015 ª2015 Elsevier Ltd All rights reserved 339
mutants) in 75 ml of reaction volume for 20–180 min at 37C. To quench the re-
action, 20 ml of the reaction mixture was added to negatively charged P81 pa-
per disks (Whatman), and the paper disks were immediately placed in wash
buffer (10 mM HEPES, pH 7.5). The paper disks were washed three times, at
5 min per wash, to remove unreacted acetyl-CoA. The papers were then dried
with acetone and added to 4 ml of scintillation fluid, and the signal was
measured with a Packard Tri-Carb 1500 liquid scintillation analyzer. Back-
ground control reactions were performed in the absence of enzyme or in the
absence of substrate peptide to ensure that any possible signal due to autoa-
cetylation was negligible. Each reaction was performed in triplicate. Complica-
tions from product inhibition at high peptide concentrations kept us from
generating full catalytic curves. However, by keeping the substrate concentra-
tion far below Km, we were able to plot velocity versus [substrate] and use the
slope of the resulting line to obtain kcat/Km values for the mutants based on the
equation: v = (kcat/Km)[E][S]. The counts per minute were converted to molar
units using a standard curve of known [14C]acetyl-CoA concentrations in scin-
tillation fluid. The assay was performed in the same manner for substrate pep-
tides corresponding to the first five and eight residues of human H4 (SGRGK
and SGRGKGGK, respectively) with wild-type hNatD.
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